Company filings profile · CIK 0001729427
CNS Pharmaceuticals, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for CNS Pharmaceuticals, Inc. (CNSP): 8 filings in the last 90 days vs 13 in the prior 90 (filing-velocity cooling ↓ · 0.62×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 3, 2026. Source-linked, daily-refreshed.
Material 8-K events — CNS Pharmaceuticals, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 2, 2026 | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| Jul 2, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 4, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Mar 11, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 2, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Feb 17, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Dec 17, 2025 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Nov 21, 2025 | Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Item 5.07; Financial Statements and Exhibits | ↗ |
Watch CNS Pharmaceuticals, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 2, 2026 | 8-K | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| Aug 25, 2026 | DEFA14A | DEFA14A | ↗ |
| Aug 21, 2026 | DEF 14A | DEFINITIVE NOTICE AND PROXY STATEMENT | ↗ |
| Aug 18, 2026 | 4 | ↗ | |
| Aug 18, 2026 | 3 | ↗ | |
| Aug 18, 2026 | 4 | ↗ | |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 12, 2026 | 10-Q | FORM 10-Q FOR JUN 2026 | ↗ |
| Jul 2, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 26, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| May 26, 2026 | 424B3 | 424B3 PROSPECTUS | ↗ |
| May 22, 2026 | CORRESP | ↗ | |
| May 22, 2026 | UPLOAD | ↗ | |
| May 20, 2026 | 4 | ↗ | |
| May 19, 2026 | D | Item 06b | ↗ |
| May 19, 2026 | S-3 | FORM S-3 REGISTRATION STATEMENT | ↗ |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 14, 2026 | 10-Q | FORM 10-Q FOR MAR 2026 | ↗ |
| May 4, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Apr 30, 2026 | 10-K/A | AMENDMENT #1 TO FORM 10-K | ↗ |
| Apr 17, 2026 | SCHEDULE 13G | ↗ | |
| Mar 31, 2026 | 10-K | FORM 10-K FOR DEC 2025 | ↗ |
| Mar 11, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 4, 2026 | 4 | ↗ | |
| Mar 4, 2026 | 3 | ↗ | |
| Mar 4, 2026 | 4 | ↗ | |
| Mar 4, 2026 | 3 | ↗ | |
| Mar 2, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Feb 27, 2026 | S-8 | FORM S-8 | ↗ |
| Feb 17, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A | ↗ | |
| Jan 2, 2026 | 4 | ↗ | |
| Jan 2, 2026 | 3 | ↗ | |
| Dec 17, 2025 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Nov 21, 2025 | 8-K | Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Item 5.07; Financial Statements and Exhibits | ↗ |
| Nov 19, 2025 | 4 | ↗ | |
| Nov 19, 2025 | 4 | ↗ | |
| Nov 19, 2025 | 4 | ↗ | |
| Nov 19, 2025 | 4 | ↗ | |
| Nov 19, 2025 | 4 | ↗ |